A study to investigate efficacy and safety with SAR445399 in adult participants with moderate to severe hidradenitis suppurativa

Trial Identifier: DRI20674
Sponsor: Sanofi
Start Date: December 2025
Primary Completion Date: September 2027
Study Completion Date: December 2027
Condition: Hidradenitis

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
CHINA Beijing, CHINA, 100730
HUNGARY Debrecen, HUNGARY, 4032
UNITED STATES, California North Hollywood, California, UNITED STATES, 91606
UNITED STATES, Florida Miami, Florida, UNITED STATES, 33173
UNITED STATES, New York New York, UNITED STATES, 10023